Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $584.86 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $378.43 | 23 | $0 (2019) |
| Mallinckrodt LLC | $65.15 | 3 | $0 (2018) |
| Travere Therapeutics, Inc. | $50.32 | 3 | $0 (2023) |
| Novo Nordisk Inc | $24.19 | 1 | $0 (2021) |
| Lilly USA, LLC | $22.11 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $19.63 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $14.41 | 1 | $0 (2018) |
| Cumberland Pharmaceuticals, Inc. | $10.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.11 | 1 | Lilly USA, LLC ($22.11) |
| 2023 | $15.38 | 1 | Travere Therapeutics, Inc. ($15.38) |
| 2022 | $15.38 | 1 | Travere Therapeutics, Inc. ($15.38) |
| 2021 | $24.19 | 1 | Novo Nordisk Inc ($24.19) |
| 2020 | $19.56 | 1 | Travere Therapeutics, Inc. ($19.56) |
| 2019 | $113.65 | 8 | Otsuka America Pharmaceutical, Inc. ($113.65) |
| 2018 | $112.06 | 8 | Otsuka America Pharmaceutical, Inc. ($82.65) |
| 2017 | $262.53 | 13 | Otsuka America Pharmaceutical, Inc. ($182.13) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Neuroscience | ||||||
| 07/27/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.38 | General |
| 12/09/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.38 | General |
| 05/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Diabetes | ||||||
| 10/21/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Kidney Stones | ||||||
| 11/20/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEPHROLOGY | ||||||
| 10/15/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEPHROLOGY | ||||||
| 09/16/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEPHROLOGY | ||||||
| 07/16/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/23/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/01/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEPHROLOGY | ||||||
| 02/14/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEPHROLOGY | ||||||
| 01/29/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEPHROLOGY | ||||||
| 06/28/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEPHROLOGY | ||||||
| 06/12/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: NEPHROLOGY | ||||||
| 05/30/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEPHROLOGY | ||||||
| 05/02/2018 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/12/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 02/08/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEPHROLOGY | ||||||
| 01/16/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEPHROLOGY | ||||||
| 12/19/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 12/11/2017 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: STRUCTURAL HEART | ||||||
| 11/30/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: NEPHROLOGY | ||||||
| 11/16/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,267 | 2,293 | $579,090 | $209,825 |
| 2022 | 16 | 1,247 | 2,174 | $540,685 | $200,351 |
| 2021 | 14 | 1,180 | 2,181 | $533,105 | $189,674 |
| 2020 | 21 | 1,158 | 2,328 | $548,685 | $171,195 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 295 | 907 | $272,100 | $90,883 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 500 | $125,000 | $36,378 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 197 | 197 | $49,250 | $28,013 | 56.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 24 | 142 | $35,500 | $12,436 | 35.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 129 | 130 | $24,050 | $9,850 | 41.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $13,500 | $8,487 | 62.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 142 | 147 | $14,700 | $4,994 | 34.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 17 | $6,800 | $4,154 | 61.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 12 | 23 | $9,200 | $3,750 | 40.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 17 | 29 | $5,800 | $3,323 | 57.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 11 | 24 | $6,000 | $2,096 | 34.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $4,200 | $1,427 | 34.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 15 | 18 | $3,150 | $1,265 | 40.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 26 | $3,900 | $1,204 | 30.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 16 | $2,400 | $675.84 | 28.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 21 | $2,100 | $442.47 | 21.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $1,200 | $398.16 | 33.2% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 12 | 12 | $240.00 | $49.80 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 307 | 847 | $254,100 | $88,184 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 259 | 438 | $109,500 | $32,757 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 217 | 217 | $54,250 | $31,527 | 58.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 123 | 124 | $22,940 | $8,711 | 38.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 22 | 107 | $26,750 | $8,191 | 30.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 23 | 29 | $11,600 | $7,244 | 62.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 105 | $15,750 | $5,169 | 32.8% |
About Dr. Syed Raza, MD
Dr. Syed Raza, MD is a Internal Medicine healthcare provider based in Hackettstown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194704585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Raza, MD has received a total of $584.86 in payments from pharmaceutical and medical device companies, with $22.11 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($584.86).
As a Medicare-enrolled provider, Raza has provided services to 4,852 Medicare beneficiaries, totaling 8,976 services with total Medicare billing of $771,045. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hackettstown, NJ
- Active Since 01/13/2006
- Last Updated 04/30/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194704585
Products in Payments
- SAMSCA (Drug) $212.07
- JYNARQUE (Drug) $166.36
- ACTHAR (Biological) $65.15
- Ozempic (Drug) $24.19
- AMYVID (Drug) $22.11
- WATCHMAN (Device) $19.63
- (815) Thiola (Drug) $19.56
- PRALUENT ALIROCUMAB INJECTION (Biological) $14.41
- Vaprisol (Drug) $10.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hackettstown
Dr. Sanjay Kavathia, M.d, M.D
Internal Medicine — Payments: $16,054
Dr. Sandira Segaram, M.d., F.a.c.p, M.D., F.A.C.P
Internal Medicine — Payments: $9,446
Dr. Lillian Theune, D.o, D.O
Internal Medicine — Payments: $5,606
Keri Ingrassia-Squiers, Do, DO
Internal Medicine — Payments: $4,471
Vineet Sandhu
Internal Medicine — Payments: $3,129
Jimmy Chang, M.d, M.D
Internal Medicine — Payments: $3,000